Boston Scientific restores manufacturing operations after incident
The company is fulfilling orders with minimal delays, thanking employees and customers for patience during recovery.
See the latest news and media coverage for Boston Scientific. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global medical device manufacturer
bostonscientific.comLast updated
In short: Boston Scientific lowered its 2026 growth outlook, recalled various medical products, and invested $1.5 billion in heart valve technology.
The company is fulfilling orders with minimal delays, thanking employees and customers for patience during recovery.
GAAP net income rose to $907 million, adjusted EPS $0.86 beat guidance, and full-year organic growth guided at 5-6%.
The eCoin System is a tibial nerve stimulator for urge urinary incontinence.
The SEISMIQ 4CE catheter met primary safety and effectiveness endpoints for treating severe coronary artery disease.
AGCO, BSX and BBWI have been added to the Zacks Rank #5 (Strong Sell) List on September 16th, 2026.
Medical technology solutions company Boston Scientific has recalled its Imager II Angiographic Catheters, which were distributed to Polokwane Provincial and Dr George Mukhari Hospitals.
Boston Scientific warns that the cyberattack will hit Q3, but recovery may delay—not lose—revenue. Click here to read this latest analysis of BSX stock.
On September 3, the FDA published a consumer-facing recall notice for an action it had already classified a month earlier: ...
Track Boston Scientific and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Boston Scientific and other trending companies.